Month: January 2022

SAN DIEGO, Jan. 19, 2022 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™, the leading software solutions for visualization, interpretation and reporting of genomic data, today announced that it will financially support the ACMG Foundation for Genetic and Genomic Medicine and its Next Generation Fellowship & Residency Training Awards Program in genetics and genomics. Patients with genetic and genomic disorders require access to medical professionals who are qualified to analyze and treat their often extremely rare conditions. Due to shortages in medical professionals in specialty areas of clinical genomics, it can be difficult for a patient to connect with board-certified PhDs or MDs in medical genetics and genomics. The Next...

Demonstrates Energizing 100MW, Scaling to 3EH ALBANY, N.Y., Jan. 19, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Soluna Holdings, Inc. (“SHI” or the “Company”), (NASDAQ: SLNH) (NASDAQ: SLNHP), the parent company of Soluna Computing, Inc. (“SCI”), a developer of green data centers for cryptocurrency mining and other intensive computing, today provided its 2022 earnings power illustration. Michael Toporek, CEO of Soluna Holdings, stated, “Following a strong 2021, we are pleased to provide our 2022 earnings power illustration to help our investors fully comprehend the strength and potential of our business as our team continues to execute on our growth plan. As you will see in the illustration, even at significantly lower BTC prices, we will generate meaningful revenue and strong contribution margin. We remain fully...

Lithium Power International Limited is pleased to release the results of its updated Definitive Feasibility Study for the Stage One Maricunga Lithium Brine project.Maricunga Stage One DFS delivers US$1.4B NPV (after tax) at an 8% discount rate An IRR of 39.6% and a 2-year payback period OPEX of US$3,718 per tonne of LCE produced Annual EBITDA of US$324M Direct development cost US$419M, Indirect cost US$145M and Contingency US$62M for a total project CAPEX of US$626M 15,200 tonnes of LCE per annum over 20 yearsHighlightsThe updated Maricunga Stage One Lithium Brine project’s Definitive Feasibility Study (DFS) supports 15,200 tonnes per annum production of lithium carbonate (LCE) for 20 years. Project NPV1 (leveraged basis) of US$1.425B (after tax) at 8% discount rate, providing an IRR of 39.6% and a 2-year payback. Estimated steady-state...

SAN DIEGO, Jan. 19, 2022 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™, the leading software solutions for visualization, interpretation and reporting of genomic data, today announced that it will financially support the ACMG Foundation for Genetic and Genomic Medicine and its Next Generation Fellowship & Residency Training Awards Program in genetics and genomics. Patients with genetic and genomic disorders require access to medical professionals who are qualified to analyze and treat their often extremely rare conditions. Due to shortages in medical professionals in specialty areas of clinical genomics, it can be difficult for a patient to connect with board-certified PhDs or MDs in medical genetics and genomics. The Next...

OLD GREENWICH, Conn., Jan. 19, 2022 (GLOBE NEWSWIRE) — Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) (“Star Equity” or the “Company”), a diversified holding company, today announced the pricing of an underwritten public offering of 9,500,000 shares of its common stock (or pre-funded warrants to purchase shares of common stock in lieu thereof) and warrants to purchase up to 9,500,000 shares of the Company’s common stock (the “common warrants”). Each share of common stock (or pre-funded warrant in lieu thereof) is being sold together with one common warrant to purchase one share of common stock at a price of $1.50 per share and common warrant. Gross proceeds, before deducting underwriting discounts and offering expenses, are expected to be approximately $14.25 million. The common warrants will be immediately exercisable at a price...

Vancouver, British Columbia, Jan. 19, 2022 (GLOBE NEWSWIRE) — Roadman Investments Corp. (TSXV:LITT) (FWB:1QD) (OTC:RMANF) (“Roadman Investments” or the “Company”) a Canadian Venture Capital and Advisory Firm,  announces that it will be consolidating all of the issued and outstanding common shares of the Company (“Common Shares”) on the basis of one (1) postconsolidation Common Share for each ten (10) preconsolidation Common Shares (the “Consolidation”). Trading of the Common Shares on a post-Consolidation basis on TSX Venture Exchange (the “TSXV”) will commence on or about January 24, 2022. The Company’s name and trading symbol LITT unchanged. The Consolidation is expected to result in the number of issued and outstanding Common Shares being reduced from 200,787,636 pre-consolidation...

HONG KONG, SHANGHAI and FLORHAM PARK, N.J., Jan. 19, 2022 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated a Phase I trial in China of HMPL-653, an investigational novel, highly selective, and potent colony-stimulating factor 1 receptor (“CSF-1R”) inhibitor. The first patient received their first dose on January 18, 2022. The Phase I trial is a multicenter, open-label, single-arm study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of HMPL-653 in the treatment of patients with advanced or metastatic solid tumors and tenosynovial giant cell tumors (“TGCT”). Approximately 110 patients are expected to be enrolled in the dose escalation and expansion phase of this study. The primary endpoints are dose limiting toxicity, safety,...

VANCOUVER, British Columbia, Jan. 19, 2022 (GLOBE NEWSWIRE) — Endeavour Silver Corp. (“Endeavour” or the “Company”) (TSX: EDR, NYSE: EXK) announces today that it filed two technical reports (the “Technical Reports”) prepared in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects. The Technical Reports are titled “NI 43-101 Technical Report: Updated Mineral Resource and Reserve Estimates for the Guanaceví Project, Durango State, Mexico” and “NI 43-101 Technical Report: Updated Mineral Resource and Reserve Estimates for the Bolañitos Project, Guanajuato State, Mexico”. Both Technical Reports have an effective date of December 31, 2020 and support the disclosure made by the Company in its February 3, 2021 news release announcing the updated 2020 Mineral Reserve and Resource Estimates. There are...

New York, NY, Jan. 19, 2022 (GLOBE NEWSWIRE) — Welsbach Technology Metals Acquisition Corp. (NASDAQ: WTMAU) (the “Company”) announced that, commencing January 20, 2022, holders of the units sold in the Company’s initial public offering may elect to separately trade shares of the Company’s common stock and rights included in the units. No fractional rights will be issued upon separation of the units and only whole rights will trade. Common stock and rights that are separated will trade on the Nasdaq Global Market under the symbols “WTMA” and “WTMAR,” respectively. Those units not separated will continue to trade on the Nasdaq Global Market under the symbol “WTMAU.” This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities of the Company, nor shall there be any sale of these securities...

LOS ANGELES, Jan. 19, 2022 (GLOBE NEWSWIRE) — Preferred Bank (NASDAQ: PFBC), one of the larger independent California banks, today reported results for the quarter and year ended December 31, 2021. Preferred Bank (“the Bank”) reported net income of $26.4 million or $1.80 per diluted share for the fourth quarter of 2021. This is an increase of $5.5 million or 26.5% over the same quarter last year and up from the $26.1 million or $1.76 per share posted in the third quarter of 2021. The primary reasons for the increase compared to the prior year was a $4.2 million provision for credit losses recorded in the fourth quarter of last year as compared to a reversal of $900,000 in allowance for credit losses (“ACL”) this quarter, a difference of $5.1 million. In comparison to the third quarter of 2021, net interest income increased $1.7...